Id2 ablation also led to decreased frequencies of adoptive Ki-67-expressing OVA-specific CD8+ T cells in tumors and tumor-draining lymph nodes (tdLNs) (Fig. 4C). This evidence concerns the gene ID2 and neoplasm.